In Vivo | Growth Anticipated For RNA Therapies In New Indications
DTx Pharma featured in In Vivo Informa Pharma Intelligence. September 1, 2021. Scroll down to read more.
DTx Pharma to Participate in the 8th Annual Fall Private Company Showcase with Solebury Trout and BMO
SAN DIEGO--(BUSINESS WIRE)--DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, today announced that [...]
DTx Pharma to Present at the OIS Retina Innovation Showcase
San Diego – October 5, 2021 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]